Alvotech, Dr. Reddy’s Partner to Commercialize AVT03 Biosimilar in US, Europe, UK
HYDERABAD, INDIA & REYKJAVIK, ICELAND (May 22, 2024) — Alvotech , a global biotech company specializing in the development and…
Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India
Hyderabad India; April 11, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred…
Dr. Reddy’s Announces Launch of D2C E-Commerce Website ‘Celevida Wellness’ for Diabetes
India; October 26, 2023 – Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, today announced the launch of its first…